LIMINAL BIOSCIENCES REÇOIT UNE ORDONNANCE FINALE DU TRIBUNAL CONCERNANT LE PLAN D’ARRANGEMENT AVEC STRUCTURED ALPHA LP

LAVAL, Québec et CAMBRIDGE, Angleterre, 20 septembre 2023 /PRNewswire/ — Liminal BioSciences Inc. (Nasdaq: LMNL) (« Liminal BioSciences » ou la « Société »), a le plaisir d’annoncer qu’elle a reçu l’ordonnance finale de la Cour supérieure de justice de l’Ontario (liste commerciale)…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.